Chii‐Min Hwu

6.7k total citations
174 papers, 2.1k citations indexed

About

Chii‐Min Hwu is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Chii‐Min Hwu has authored 174 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Endocrinology, Diabetes and Metabolism, 48 papers in Epidemiology and 35 papers in Surgery. Recurrent topics in Chii‐Min Hwu's work include Diabetes Treatment and Management (52 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (31 papers) and Liver Disease Diagnosis and Treatment (28 papers). Chii‐Min Hwu is often cited by papers focused on Diabetes Treatment and Management (52 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (31 papers) and Liver Disease Diagnosis and Treatment (28 papers). Chii‐Min Hwu collaborates with scholars based in Taiwan, United States and Singapore. Chii‐Min Hwu's co-authors include Fu‐Shun Yen, James Cheng‐Chung Wei, Rima Boyadjian, Ella Kogosov, Mohammed Saad, Sujata Jinagouda, Chih‐Cheng Hsu, Chih‐Cheng Hsu, Kuang‐Chung Shih and L. Hsiao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Chii‐Min Hwu

157 papers receiving 2.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Chii‐Min Hwu 928 582 509 421 328 174 2.1k
Marcos Antônio Tambascia 1.5k 1.6× 798 1.4× 717 1.4× 356 0.8× 545 1.7× 82 3.2k
Dimitrios N. Kiortsis 811 0.9× 617 1.1× 727 1.4× 198 0.5× 767 2.3× 98 3.2k
Paloma Almeda‐Valdés 848 0.9× 481 0.8× 808 1.6× 133 0.3× 287 0.9× 98 2.2k
Paola Lucidi 1.0k 1.1× 825 1.4× 249 0.5× 454 1.1× 536 1.6× 58 2.3k
José Manuel Gómez 924 1.0× 977 1.7× 737 1.4× 335 0.8× 734 2.2× 91 3.7k
Leo Cornelius Bollheimer 632 0.7× 1.2k 2.1× 630 1.2× 276 0.7× 548 1.7× 68 2.8k
Chan‐Hee Jung 989 1.1× 493 0.8× 562 1.1× 118 0.3× 428 1.3× 104 2.4k
Jing Hong 885 1.0× 463 0.8× 519 1.0× 122 0.3× 255 0.8× 104 2.0k
Takuro Okamura 609 0.7× 1.2k 2.0× 512 1.0× 119 0.3× 264 0.8× 126 2.6k
Elisabetta Dall’Aglio 1.2k 1.3× 651 1.1× 405 0.8× 107 0.3× 405 1.2× 62 2.6k

Countries citing papers authored by Chii‐Min Hwu

Since Specialization
Citations

This map shows the geographic impact of Chii‐Min Hwu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chii‐Min Hwu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chii‐Min Hwu more than expected).

Fields of papers citing papers by Chii‐Min Hwu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chii‐Min Hwu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chii‐Min Hwu. The network helps show where Chii‐Min Hwu may publish in the future.

Co-authorship network of co-authors of Chii‐Min Hwu

This figure shows the co-authorship network connecting the top 25 collaborators of Chii‐Min Hwu. A scholar is included among the top collaborators of Chii‐Min Hwu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chii‐Min Hwu. Chii‐Min Hwu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yen, Fu‐Shun, et al.. (2025). Sodium‐Glucose Cotransporter 2 Inhibitors Use in Patients With Liver Cirrhosis. Diabetes/Metabolism Research and Reviews. 41(5). e70070–e70070.
2.
Yen, Fu‐Shun, et al.. (2025). The impact of sodium-glucose cotransporter-2 inhibitors on dialysis risk and mortality in kidney transplant patients with diabetes. American Journal of Transplantation. 25(9). 1954–1964.
3.
Yeh, Chang‐Ching, et al.. (2025). A Prospective Study to Determine Trimester-Specific Thyroid Function Reference Intervals. Journal of Endocrinological Investigation. 48(10). 2351–2360.
4.
Yen, Fu‐Shun, et al.. (2025). SGLT2 inhibitors for primary prevention of macrovascular and major microvascular complications in type 2 diabetes: an island-wide cohort study. Journal of the Royal Society of Medicine. 118(11). 347–357.
5.
Kuo, Chin‐Sung, Yau‐Jiunn Lee, Lee‐Ming Chuang, et al.. (2024). Residual risk of cardiovascular complications in statin-using patients with type 2 diabetes: the Taiwan Diabetes Registry Study. Lipids in Health and Disease. 23(1). 24–24. 4 indexed citations
6.
Wang, Wei‐Ting, Leay‐Kiaw Er, Chien‐Wei Huang, et al.. (2024). Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review. Hypertension Research. 47(5). 1103–1119. 5 indexed citations
7.
8.
Yen, Fu‐Shun, et al.. (2024). Impact of family income on the development of gestational diabetes mellitus and the associated birth outcomes: A nationwide study. Journal of Diabetes Investigation. 16(1). 51–59. 2 indexed citations
9.
Yen, Fu‐Shun, et al.. (2024). Microvascular disease and its association with dementia in patients with type 2 diabetes: A nationwide cohort study in Taiwan. Diabetes Obesity and Metabolism. 26(11). 5399–5407. 2 indexed citations
10.
Hang, Jen‐Fan, et al.. (2024). Difficulties of Preoperative Diagnosis of Cribriform Morular Thyroid Carcinoma. SHILAP Revista de lepidopterología. 2024. 1–6.
11.
Yen, Fu‐Shun, et al.. (2023). Is a low‐carbohydrate, high‐fat diet feasible for people with type 2 diabetes and nonalcoholic fatty liver disease?. Journal of Diabetes Investigation. 14(8). 930–932. 2 indexed citations
12.
Li, Jiazhen, et al.. (2023). Determination of the Elemental Iodine in Human Breast Milk by Inductively Coupled Plasma mass Spectrometry. Biological Trace Element Research. 202(4). 1517–1523. 2 indexed citations
13.
Chang, Yu‐Ling, Bo‐Ching Lee, Ching‐Chu Lu, et al.. (2023). Strategies for subtyping primary aldosteronism. Journal of the Formosan Medical Association. 123. S114–S124. 4 indexed citations
14.
15.
Yen, Fu‐Shun, et al.. (2023). Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort Study. Pharmaceuticals. 16(5). 643–643. 2 indexed citations
16.
Yen, Fu‐Shun, et al.. (2023). Diet and exercise are a fundamental part of comprehensive care for type 2 diabetes. Journal of Diabetes Investigation. 14(8). 936–939. 11 indexed citations
17.
Hwu, Chii‐Min, et al.. (2023). Analytical validation of an inductively coupled plasma mass spectrometry method for urinary iodine concentration measurements in Taiwan. Journal of the Formosan Medical Association. 122(8). 757–765. 12 indexed citations
18.
Hwu, Chii‐Min, et al.. (2022). Soluble tumor necrosis factor receptor 2 is associated with progressive diabetic kidney disease in patients with type 2 diabetes mellitus. PLoS ONE. 17(4). e0266854–e0266854. 7 indexed citations
19.
Yen, Fu‐Shun, et al.. (2022). Sulfonylurea Use in Patients with Type 2 Diabetes and COPD: A Nationwide Population-Based Cohort Study. International Journal of Environmental Research and Public Health. 19(22). 15013–15013. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcos Antônio Tambascia Breakdown of academic impact, for papers by Dimitrios N. Kiortsis Breakdown of academic impact, for papers by Paloma Almeda‐Valdés Breakdown of academic impact, for papers by Paola Lucidi Breakdown of academic impact, for papers by José Manuel Gómez Breakdown of academic impact, for papers by Leo Cornelius Bollheimer Breakdown of academic impact, for papers by Chan‐Hee Jung Breakdown of academic impact, for papers by Jing Hong Breakdown of academic impact, for papers by Takuro Okamura Breakdown of academic impact, for papers by Elisabetta Dall’Aglio
Rankless by CCL
2026